These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 33509706)

  • 1. Complex and prolonged hypercoagulability in coronavirus disease 2019 intensive care unit patients: A thromboelastographic study.
    Cordier PY; Pierrou C; Noel A; Paris R; Gaudray E; Martin E; Contargyris C; Bélot-De Saint Léger F; Lyochon A; Astier H; Desmots F; Savini H; Surcouf C
    Aust Crit Care; 2021 Mar; 34(2):160-166. PubMed ID: 33509706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.
    Panigada M; Bottino N; Tagliabue P; Grasselli G; Novembrino C; Chantarangkul V; Pesenti A; Peyvandi F; Tripodi A
    J Thromb Haemost; 2020 Jul; 18(7):1738-1742. PubMed ID: 32302438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia.
    Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
    J Thromb Thrombolysis; 2020 Aug; 50(2):281-286. PubMed ID: 32394236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
    Bocci MG; Maviglia R; Consalvo LM; Grieco DL; Montini L; Mercurio G; Nardi G; Pisapia L; Cutuli SL; Biasucci DG; Gori C; Rosenkranz R; De Candia E; Carelli S; Natalini D; Antonelli M; Franceschi F
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12466-12479. PubMed ID: 33336766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of coagulation status using viscoelastic testing in intensive care patients with coronavirus disease 2019 (COVID-19): An observational point prevalence cohort study.
    Collett LW; Gluck S; Strickland RM; Reddi BJ
    Aust Crit Care; 2021 Mar; 34(2):155-159. PubMed ID: 32773357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational study.
    Tsantes AE; Frantzeskaki F; Tsantes AG; Rapti E; Rizos M; Kokoris SI; Paramythiotou E; Katsadiotis G; Karali V; Flevari A; Chrysanthopoulou E; Maratou E; Kyriakou E; Gialeraki A; Bonovas S; Dimopoulos G; Tsangaris I; Armaganidis A
    Medicine (Baltimore); 2020 Nov; 99(47):e23365. PubMed ID: 33217881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboelastography Profiles of Critically Ill Patients With Coronavirus Disease 2019.
    Yuriditsky E; Horowitz JM; Merchan C; Ahuja T; Brosnahan SB; McVoy L; Berger JS
    Crit Care Med; 2020 Sep; 48(9):1319-1326. PubMed ID: 32618696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection.
    Wright FL; Vogler TO; Moore EE; Moore HB; Wohlauer MV; Urban S; Nydam TL; Moore PK; McIntyre RC
    J Am Coll Surg; 2020 Aug; 231(2):193-203.e1. PubMed ID: 32422349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.
    Spiezia L; Boscolo A; Poletto F; Cerruti L; Tiberio I; Campello E; Navalesi P; Simioni P
    Thromb Haemost; 2020 Jun; 120(6):998-1000. PubMed ID: 32316063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercoagulable viscoelastic blood clot characteristics in critically ill coronavirus disease 2019 patients and associations with thrombotic complications.
    Roh DJ; Eiseman K; Kirsch H; Yoh N; Boehme A; Agarwal S; Park S; Connolly ES; Claassen J; Wagener G
    J Trauma Acute Care Surg; 2021 Jan; 90(1):e7-e12. PubMed ID: 33009340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of D-dimer and Fibrinogen With Hypercoagulability in COVID-19 Requiring Extracorporeal Membrane Oxygenation.
    Chandel A; Patolia S; Looby M; Bade N; Khangoora V; King CS
    J Intensive Care Med; 2021 Jun; 36(6):689-695. PubMed ID: 33641491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidics contrasted to thrombelastography: perplexities in defining hypercoagulability.
    Lawson PJ; Moore HB; Moore EE; Gerich ME; Stettler GR; Banerjee A; Schulick RD; Nydam TL
    J Surg Res; 2018 Nov; 231():54-61. PubMed ID: 30278969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Thromboelastography and velocity curve derivative in diagnosing COVID-19 associated coagulopathy.
    Mohan G; Wilson W; Paonam B; Vaidya A; Ravindra P; Shastry S; Balakrishnan JM; Rao S; Chaudhuri S
    Int J Lab Hematol; 2022 Oct; 44(5):823-830. PubMed ID: 35609623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Proportion of Patients With Musculoskeletal Tumors Demonstrate Thromboelastographic Markers of Hypercoagulability? A Pilot Study.
    Sabharwal S; Jalloh HB; Levin AS; Morris CD
    Clin Orthop Relat Res; 2023 Mar; 481(3):553-561. PubMed ID: 35901446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of enzymatic from platelet hypercoagulability using the novel thrombelastography parameter delta (delta).
    Gonzalez E; Kashuk JL; Moore EE; Silliman CC
    J Surg Res; 2010 Sep; 163(1):96-101. PubMed ID: 20605586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill.
    Mortus JR; Manek SE; Brubaker LS; Loor M; Cruz MA; Trautner BW; Rosengart TK
    JAMA Netw Open; 2020 Jun; 3(6):e2011192. PubMed ID: 32501489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.
    Maatman TK; Jalali F; Feizpour C; Douglas A; McGuire SP; Kinnaman G; Hartwell JL; Maatman BT; Kreutz RP; Kapoor R; Rahman O; Zyromski NJ; Meagher AD
    Crit Care Med; 2020 Sep; 48(9):e783-e790. PubMed ID: 32459672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboelastography findings in critically ill COVID-19 patients.
    Salem N; Atallah B; El Nekidy WS; Sadik ZG; Park WM; Mallat J
    J Thromb Thrombolysis; 2021 May; 51(4):961-965. PubMed ID: 33011896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients.
    Kashuk JL; Moore EE; Sabel A; Barnett C; Haenel J; Le T; Pezold M; Lawrence J; Biffl WL; Cothren CC; Johnson JL
    Surgery; 2009 Oct; 146(4):764-72; discussion 772-4. PubMed ID: 19789037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study.
    Neethling C; Calligaro G; Miller M; Opie JJS
    Thromb J; 2021 Nov; 19(1):83. PubMed ID: 34742307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.